Artículo

Effects of third generation beta-blockers, atenolol or amlodipine on blood pressure variability and target organ damage in spontaneously hypertensive rats

del Mauro, Julieta Sofía ; Prince, Paula Denise Icon; Allo, Miguel Angel ; Santander Plantamura, Yanina Alejandra ; Moretton, Marcela Analía Icon; González, Germán Esteban Icon; Bertera, Facundo Martin ; Carranza, Andrea ; Gorzalczany, Susana Beatriz ; Chiappetta, Diego Andrés Icon; Morales, Celina ; Gelpi, Ricardo Jorge Icon; Taira, Carlos Alberto Icon; Polizio, Ariel Héctor Icon; Donato, Martin Alejandro ; Hocht, Christian

Otros responsables

Fecha

03/2020

Editorial

Lippincott Williams

Revista

Journal of Hypertension

Título del libro

Nombre del evento

Fecha del evento

Institución organizadora

ISSN

0263-6352

eISSN

ISBN

Idioma

Inglés

Tipo del evento

Clasificación temática

Resumen

Background: b-blockers are no longer considered as firstline antihypertensive drugs due to their lower cardioprotection. Method: Considering the differences in the pharmacological properties of b-blockers, the present work compared the effects of third-generation bblockers – carvedilol and nebivolol – with a first-line agent – amlodipine – on hemodynamic parameters, including short-term blood pressure variability (BPV), and their ability to prevent target organ damage in spontaneously hypertensive rats (SHR). SHR rats were orally treated with carvedilol, nebivolol, atenolol, amlodipine or vehicle for 8 weeks. Wistar Kyoto rats treated with vehicle were used as normotensive group. Echocardiographic evaluation, BP, and short-term BPV measurements were performed. Left ventricle and thoracic aorta were removed for histological evaluations and to assess the expression of transforming growth factor b (TGF-b), tumor necrosis factor-a (TNF-a) and interleukin-6 (IL-6). Results: Carvedilol, nebivolol or amlodipine induced a greater reduction of carotid BP, short-term BPV and echocardiography parameters than atenolol in SHR rats. Carvedilol, nebivolol and amlodipine were more effective than atenolol in the prevention of cardiac hypertrophy, and cardiac and aortic collagen deposit. Carvedilol and nebivolol, but not atenolol, reduced the expressions of fibrotic and inflammatory biomarkers – TGF-b, TNF-a and IL-6 – in SHR rats to a similar extent to that of amlodipine. Conclusion: Chronic treatment with carvedilol or nebivolol attenuates carotid BP and short-term BPV, and reduces target organ damage in SHR to a greater extent than atenolol. Our findings suggest that the lower cardiovascular protection of nonvasodilating b-blockers, as atenolol, in hypertension must not be translated to thirdgeneration b-blockers. Keywords: amlodipine, atenolol, blood pressure variability, carvedilol, nebivolol, spontaneously hypertensive rats, target organ damage Abbreviations: BP, blood pressure; BPV, blood pressure variability; CV, coefficient of variation; D. Post. WT, diastolic posterior wall thickness; HR, heart rate; ICF, interstitial collagen fraction; IL-6, interleukin-6; IVRT, isovolumic relaxation time; LVEDD, left ventricular end diastolic diameter; LV, left ventricular; LVWT, left ventricular wall thickness; SHR, spontaneously hypertensive rats; TGF-b, transforming growth factor b; TNF-a, tumor necrosis factor-a; TOD, target organ damage; TPGS, D-a-tocopheryl polyethylene glycol 1000 succinate; WKY, Wistar Kyoto

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa